Arbutinin İnsan Yumurtalık Kanseri Hücre Hattında in vitro Sitotoksik Aktivitesinin Araştırılması

Öz

Arbutin kozmetik ürünlerde sıklıkla kullanılan aktif bileşiklerden biridir. Bu çalışmada arbutinin yumurtalık kanseri üzerindeki olası etkileri insan seröz kistadenoma kanser hücre hattında (SKOV3) belirlenmiştir. Arbutin sitotoksisite düzeyleri ve IC50 değerleri 3-(4,5-dimetil-2-tiyazolil)-2,5-difenil-2H-tetrazolium bromür (MTT) yöntemi kullanılarak belirlenmiştir. Uygulanan doz artışına bağlı olarak arbutinin hücreler üzerinde toksik aktiviteye sahip olduğu görülmüştür. IC50 değeri uygulanan hücrelerde yapılan immünositokimyasal analiz sonucunda arbutinin IC50 dozunda SKOV3 hücrelerinde kontrol grubuna göre Kaspaz 3 immünreaktivitesini artırdığı bulunmuştur. Arbutinin IC50 dozunda SKOV3 hücrelerinde apoptotik Kaspaz 3 aktivasyonunu artırdığı göz önüne alındığında, arbutinin bu etkilerinin ardındaki moleküler mekanizmaların aydınlatılması, tedavide yeni bir bakış açısı geliştirilmesine katkı sağlayabilir.

Anahtar Kelimeler

• Arbutin
• Ovaryum kanseri
• SKOV3
• sitotoksisite
• kaspaz-3.

Investigation of in vitro Cytotoxic Activity of Arbutin on Human Ovarian Cancer Cell Line

Öz

Arbutin is one of the chemical compounds commonly found in cosmetics. Arbutin's potential effects on ovarian cancer were investigated in this study using the human serous cystadenoma cancer cell line (SKOV3). Cytotoxicity levels and IC50 values of arbutin were determined using the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) method. Depending on the increase in the applied doses, arbutin was found to have toxic activity on cancer cells. As a result of the immunocytochemical analysis performed on the cells applied with the IC50 value, it was found that arbutin at the IC50 dose increased Caspase 3 immunoreactivity in SKOV3 cells compared to the control group. Considering that arbutin increased apoptotic Caspase 3 activation in SKOV3 cells at the IC50 dose, elucidation of the molecular mechanisms behind these effects of arbutin may contribute to the development of a new perspective in treatment.

Anahtar Kelimeler

• Arbutin
• Ovarian cancer
• SKOV3
• cytotoxicity
• caspase-3.

Kaynakça

1. Berliere, M., Piette, N., Bernard, M., Lacroix, C., Gerday, A., Samartzi, V., Coyette, M., Roelants, F., …, & Duhoux, F.O.P. (2021). Hypnosis Sedation Reduces the Duration of Different Side Effects of Cancer Treatments in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy. Cancers, 13(16), 4147. https://doi.org/10.3390/cancers13164147
2. Chan, J.K., Teoh, D., Hu, J. M., Shin, J.Y., Osann, K., & Kapp, D.S. (2008). Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers. Gynecologic oncology, 109(3), 370–376. https://doi.org/10.1016/j.ygyno.2008.02.006
3. Chen, X., Wu, Y., Dong, H., Zhang, C.Y., & Zhang, Y. (2013). Platinum-based agents for individualized cancer treatment. Current molecular medicine, 13(10), 1603–1612. https://doi.org/10.2174/1566524013666131111125515
4. Cortés, A., Cascante, M., Cárdenas, M.L., & Cornish-Bowden, A. (2001). Relationships between inhibition constants, inhibitor concentrations for 50% inhibition and types of inhibition: new ways of analysing data. The Biochemical journal, 357(Pt 1), 263–268. https://doi.org/10.1042/0264-6021:3570263
5. Gajjar, K., Ogden, G., Mujahid, M.I., & Razvi, K. (2012). Symptoms and risk factors of ovarian cancer: a survey in primary care. ISRN obstetrics and gynecology, 2012, 754197. https://doi.org/10.5402/2012/754197
6. Hazman, Ö., Sarıova, A., Bozkurt, M.F., & Ciğerci, İ.H. (2021). The anticarcinogen activity of β-arbutin on MCF-7 cells: Stimulation of apoptosis through estrogen receptor-α signal pathway, inflammation and genotoxicity. Molecular and cellular biochemistry, 476(1), 349–360. https://doi.org/10.1007/s11010-020-03911-7
7. Hazman, Ö., Evin, H., Bozkurt, M.F., & Ciğerci, İ.H. (2022). Two faces of arbutin in hepatocellular carcinoma (HepG2) cells: Anticarcinogenic effect in high concentration and protective effect against cisplatin toxicity through its antioxidant and anti-inflammatory activity in low concentration. Biologia, 77(1), 225-239. https://doi.org/10.1007/s11756-021-00921-8
8. Hu, H., Zhu, S., Tong, Y., Huang, G., Tan, B., & Yang, L. (2020). Antitumor activity of triptolide in SKOV3 cells and SKOV3/DDP in vivo and in vitro. Anti-cancer drugs, 31(5), 483–491. https://doi.org/10.1097/CAD.0000000000000894

9. Khadir, F., Pouramir, M., Joorsaraee, S.G., Feizi, F., Sorkhi, H., & Yousefi, F. (2015). The effect of arbutin on lipid peroxidation and antioxidant capacity in the serum of cyclosporine-treated rats. Caspian journal of internal medicine, 6(4), 196–200.
10. Kim, J.Y., Cho, C.H., & Song, H.S. (2017). Targeted therapy of ovarian cancer including immune check point inhibitor. The Korean journal of internal medicine, 32(5), 798–804. https://doi.org/10.3904/kjim.2017.008
11. Li, H., Jeong, Y.M., Kim, S.Y., Kim, M.K., & Kim, D.S. (2011). Arbutin inhibits TCCSUP human bladder cancer cell proliferation via up-regulation of p21. Die Pharmazie, 66(4), 306–309. https://doi.org/10.1691/ph.2011.0785
12. Lim, Y.J., Lee, E.H., Kang, T.H., Ha, S.K., Oh, M.S., Kim, S.M., Yoon, T.J., Kang, C., Park, J.H., & Kim, S.Y. (2009). Inhibitory effects of arbutin on melanin biosynthesis of alpha-melanocyte stimulating hormone-induced hyperpigmentation in cultured brownish guinea pig skin tissues. Archives of pharmacal research, 32(3), 367–373. https://doi.org/10.1007/s12272-009-1309-8
13. Liu, J., Liu, X., Ma, W., Kou, W., Li, C., & Zhao, J. (2018). Anticancer activity of cucurbitacin-A in ovarian cancer cell line SKOV3 involves cell cycle arrest, apoptosis and inhibition of mTOR/PI3K/Akt signaling pathway. Journal of B.U.ON.: official journal of the Balkan Union of Oncology, 23(1), 124–128.
14. Mosmann T. (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of immunological methods, 65(1-2), 55–63. https://doi.org/10.1016/0022-1759(83)90303-4
15. Naeem, A., Hu, P., Yang, M., Zhang, J., Liu, Y., Zhu, W., & Zheng, Q. (2022). Natural Products as Anticancer Agents: Current Status and Future Perspectives. Molecules (Basel, Switzerland), 27(23), 8367. https://doi.org/10.3390/molecules27238367
16. Nahar, L., Al-Groshi, A., Kumar, A., & Sarker, S.D. (2022). Arbutin: Occurrence in Plants, and Its Potential as an Anticancer Agent. Molecules (Basel, Switzerland), 27(24), 8786. https://doi.org/10.3390/molecules27248786
17. Pečivová, J., Nosál, R., Sviteková, K., & Mačičková, T. (2014). Arbutin and decrease of potentially toxic substances generated in human blood neutrophils. Interdisciplinary toxicology, 7(4), 195–200. https://doi.org/10.2478/intox-2014-0028
18. Qiao, L.J., Li, C.Z., Ji, A., & Feng, Q. (2025). Four meroterpenoids from the leaves of Psidium guajava L. and their cytotoxicity activities. Natural product research, 1–9. https://doi.org/10.1080/14786419.2025.2469323
19. Saeedi, M., Khezri, K., Seyed Zakaryaei, A., & Mohammadamini, H. (2021). A comprehensive review of the therapeutic potential of α-arbutin. Phytotherapy research: PTR, 35(8), 4136–4154. https://doi.org/10.1002/ptr.7076
20. Shen, X., Wang, J., Wang, J., Chen, Z., Yuan, Q., & Yan, Y. (2017). High-level De novo biosynthesis of arbutin in engineered Escherichia coli. Metabolic engineering, 42, 52–58. https://doi.org/10.1016/j.ymben.2017.06.001
21. Siegel, R.L., Miller, K.D., Wagle, N.S., & Jemal, A. (2023). Cancer statistics, 2023. CA: a cancer journal for clinicians, 73(1), 17–48. https://doi.org/10.3322/caac.21763
22. Su, Y., Sun, X., Wu, R., Zhang, X., & Tu, Y. (2020). Molecular spectroscopic behaviors of beta-arbutin in anti-skin cancer. Spectroscopy Letters, 53(3), 172–183. https://doi.org/10.1080/00387010.2020.1715441
23. Surapaneni, K. M., & Arulselvan, P. (2021). Arbutin exerts anticancer activity against rat C6 glioma cells by inducing apoptosis and inhibiting the inflammatory markers and P13/Akt/mTOR cascade. Journal of biochemical and molecular toxicology, 35(9), e22857. https://doi.org/10.1002/jbt.22857
24. Xu, K.X., Xue, M.G., Li, Z., Ye, B.C., & Zhang, B. (2022). Recent Progress on Feasible Strategies for Arbutin Production. Frontiers in bioengineering and biotechnology, 10, 914280. https://doi.org/10.3389/fbioe.2022.914280
25. Yadav, P., Yadav, R., Jain, S., & Vaidya, A. (2021). Caspase-3: A primary target for natural and synthetic compounds for cancer therapy. Chemical biology & drug design, 98(1), 144–165. https://doi.org/10.1111/cbdd.13860
26. Yang, Z., Shi, H., Chinnathambi, A., Salmen, S.H., Alharbi, S.A., Veeraraghavan, V.P., Surapaneni, K.M., & Arulselvan, P. (2021). Arbutin exerts anticancer activity against rat C6 glioma cells by inducing apoptosis and inhibiting the inflammatory markers and P13/Akt/mTOR cascade. Journal of biochemical and molecular toxicology, 35(9), e22857. https://doi.org/10.1002/jbt.22857